Myriad Genetics | MYGN - Stock

Stock Price
3.65
Daily Change
0.07 1.96%
Monthly
-28.99%
Yearly
-17.61%
Q2 Forecast
3.51

Myriad Genetics reported $27.9M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Agilent USD 1.06B 34M Dec/2025
Becton, Dickinson and Co. USD 3.36B 728M Mar/2026
Bio-Rad Laboratories USD 770.5M 29.8M Mar/2026
Bruker USD 1.12B 26.9M Mar/2026
Danaher USD 2.61B 119M Mar/2026
Illumina USD 611M 47M Mar/2026
J&J USD 14.58B 392M Mar/2026
Mettler Toledo International USD 404.83M 17.6M Mar/2026
Myriad Genetics USD 27.9M 2.7M Mar/2026
OraSure Technologies USD 30.31M 753K Mar/2026
Pacific Biosciences Of California USD 51.02M 1.74M Mar/2026
Quest Diagnostics USD 225M 36M Mar/2026
Quidel USD 611.5M 33.9M Mar/2026
Repligen USD 179.26M 8.8M Mar/2026
Revvity USD 387.5M 8.01M Mar/2026
Standard Biotools USD 18.59M 1.39M Mar/2026
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Veracyte USD 21.42M 870K Mar/2026
Waters USD 1.5B 923.63M Mar/2026